Springer and the British Society for Immunology (BSI) have entered into an agreement to publish six books per year, to be included in Springer's long-running book series, Advances in Experimental Medicine and Biology. The edited volumes and monographs by renowned scientists will present the latest scientific advances in immunology research.
The books will cover fields relevant to the work of immunologists, from HIV/AIDS to allergies, diabetes, malaria, TB, animal health, arthritis, transplantation, cancer, genetics, vaccination and infectious disease. BSI will have editorial control over the content of the books and will be responsible for acquiring and commissioning the works. Springer will handle production, marketing, sales and distribution. The books will be available as eBooks on Springer's online platform SpringerLink (link.springer.com) and in print (POD).
Judith Willetts, Chief Executive of the British Society for Immunology, said, "The BSI is very excited about this new publishing initiative with Springer and the opportunity it presents. Immunology cuts across all areas of biomedical research and practice. This book series will enable us to disseminate the best of our members' research to new readers, and to showcase the quality, diversity and importance of their work."
Andrea Macaluso, Editorial Director Biomedicine at Springer, said, "Springer is privileged and pleased to have the opportunity of partnering with the British Society for Immunology. We see great value in publishing these new books on cutting-edge research in immunology. Scientists all over the world will benefit from the content, and the books will complement and expand Springer's portfolio in this field."
Founded in 1956, the British Society for Immunology (www.immunology.org) is one of the oldest, largest, and most active immunology societies in the world and is the largest in Europe. The BSI's main objective is to promote and support excellence in research, scholarship and clinical practice in immunology for the benefit of human and animal health and welfare. To meet this objective, the BSI runs innovative events in research, public engagement and education; promotes research and good practice in immunology, translational medicine and vaccination; and works to influence policy and decision makers.
Springer Science+Business Media (www.springer.com) is a leading global scientific publisher, providing researchers in academia, scientific institutions and corporate R&D departments with quality content via innovative information products and services. Springer is also a trusted local-language publisher in Europe – especially in Germany and the Netherlands – primarily for physicians and professionals working in the automotive, transport and healthcare sectors. Roughly 2,000 journals and more than 7,000 new books are published by Springer each year, and the group is home to the world's largest STM eBook collection, as well as the most comprehensive portfolio of open access journals. Springer employs nearly 6,200 individuals across the globe and in 2011 generated sales of approximately EUR 875 million.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.